XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Operating activities:    
Net income (loss) $ 14,762 $ (22,155)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Goodwill and intangible impairment 19,762 64,586
Depreciation and amortization 40,578 40,276
Amortization of deferred financing costs 541 998
Deferred income taxes (8,535) (4,390)
Bad debt expense 418 2,997
Stock-based compensation 7,641 5,941
Other non-cash items (122) (245)
Changes in operating items:    
Trade receivables (6,778) (15,977)
Inventories 31,674 57,031
Prepaid and other 4,761 2,706
Accounts payable and accrued expenses (6,077) (59,806)
Other assets and liabilities 1,426 1,102
Net cash provided by operating activities 100,051 73,064
Investing activities:    
Acquisitions, net of cash acquired 0 (5,000)
Capital expenditures (26,482) (31,351)
Net cash used in investing activities (26,482) (36,351)
Financing activities:    
Acquisition of treasury stock (9,178) (1,197)
Proceeds from exercise of employee stock options 258 0
Proceeds from bank borrowings 82,000 195,900
Repayment of bank borrowings (89,500) (210,900)
Debt issuance cost 0 (383)
Net cash used in financing activities (16,420) (16,580)
Net change in cash and cash equivalents 57,149 20,133
Cash and cash equivalents:    
Beginning of period 126,807 31,465
End of period $ 183,956 $ 51,598